Dr Gideon Hirschfield discusses some of the highlights on primary biliary cholangitis from The Liver Meeting 2023, with a focus on the RESPONSE trial of seladelpar.
This program is intended for healthcare professionals only.
Dr Gideon Hirschfield discusses some of the highlights on primary biliary cholangitis from The Liver Meeting 2023, with a focus on the RESPONSE trial of seladelpar.
Like this content?
Share with a colleague
This program is made possible thanks to an independent educational grant from Ipsen.
Email: [email protected]